Market Tracker

12/02 5:16pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.13
Delayed Data
As of Dec 02
 +0.23 / +3.90%
Today’s Change
4.39
Today|||52-Week Range
11.26
-40.89%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.90
Today’s open5.94
Day’s range5.88 - 6.17
Volume2,398,524
Average volume (3 months)1,878,874
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+5.54%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book17.30

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+1.41+5.71%
OPHTOphthotech Corp+2.21+6.87%
DEPODepomed Inc+0.39+2.10%
EGRXEagle Pharmaceutical...+0.85+1.14%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts